Biofermin Pharmaceutical. (4517.TSE) Q2 2018 Earnings

27JulExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
32.95
44.08
55.2
66.33

Details

Expected EPS
N/A
Actual EPS
66.3286
Surprise EPS
66.33
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 66.3286 per share for Q2 2018.

0 Comments

Share your thoughts